• Summit Therapeutics (NASDAQ:SMMT) Given Buy Rating at HC Wainwright

    Source: Buzz FX / 04 Oct 2024 07:41:11   America/Chicago


    Summit Therapeutics (NASDAQ:SMMT) Given Buy Rating at HC Wainwright Written by MarketBeat October 4, 2024 Share Link copied to clipboard. Summit Therapeutics ( NASDAQ:SMMT - Get Free Report ) 's stock had its "buy" rating reissued by resear
    Read more...
Share on,